Indonesia vs Serbia: Cause of death, by non-communicable diseases, ages 0-4
Indonesia
31.9%
in 2021
Serbia
31.1%
in 2021
Indonesia rank
89th
Serbia rank
91st
Cause of death, by non-communicable diseases, ages 0-4 over time
- Indonesia
- Serbia
How they compare
Indonesia currently reports 31.9% against 31.1% in Serbia, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Serbia ahead.
Indonesia ranks 89th and Serbia ranks 91st of 185 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Indonesia | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.9% | 31.1% | 19.2% | Serbia |
| 2010s | 24.0% | 30.1% | 6.2% | Serbia |
| 2020s | 31.7% | 30.4% | 1.3% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Indonesia or Serbia?
- Indonesia, at 31.9% against 31.1% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Indonesia and Serbia?
- 0.8%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Indonesia and Serbia rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Indonesia ranks 89th and Serbia ranks 91st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.